Salbutamol Completed Phase 1 Trials for Sickle Cell Disorders Diagnostic

IndicationsStatusPurposePhase
CompletedDiagnostic1
clinicaltrials.gov IdentifierTitleDrugs
NCT01895998Quantifying the Presence of Lung Disease and Pulmonary Hypertension in Children With Sickle Cell Disease